LicianPro

Immix Biopharma, Inc. ·

IMMX 8-K 2026-09-30

Immix Biopharma, Inc. (IMMX) 8-K dated 2026-09-30 — accession 0001493152-26-045143.

Immix Biopharma, Inc. (IMMX) is a biotechnology company listed on US.

Immix Biopharma, Inc. filed a 8-K on 2026-09-30. Accession 0001493152-26-045143.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IMMX revenue for 2022-12-08 was $20.0M. IMMX currently screens at market cap $640.7M.

Not investment advice. The IMMX SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr